Conditions: Healthy
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 327
Healthy volunteers: yes

Brief summary:
Investigate the pharmacokinetics, safety and tolerability of BI695501 and to establish pharmacokinetic similarity of BI 695501 to adalimumab.

Detailed description:

Arms:
arm 1: Subject to receive one subcutaneous (s.c.) injection from a prefilled syringe containing BI 695501 arm 2: Subject to receive one subcutaneous (s.c.) injection from a prefilled syringe containing adalimumab-EU source arm 3: Subject to receive one subcutaneous (s.c.) injection from a prefilled syringe containing adalimumab-US source

Interventions: intervention 1: BI 695501 intervention 2: adalimumab-EU source intervention 3: adalimumab-US source
Intervention descriptions: intervention 1: BI 695501 single s.c. injection intervention 2: adalimumab-EU source single s.c. injection intervention 3: adalimumab-US source single s.c. injection.

Protocol document: